Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 8, 2007

Rockwell Medical Technologies, Inc.
(Exact name of registrant as specified in its charter)


Michigan 		 
000-23661 		 
38-3317208
(State or other jurisdiction
of incorporation) 		  (Commission File Number)   (IRS Employer Identification No.)


 
30142 Wixom Road,Wixom, Michigan 		 
48393 		 
  (Address of principal executive offices)   (Zip Code)  

Registrant's telephone number, including area code:   (248) 960-9009



________________________________________________________________________________
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition.

On November 8, 2007, the Company issued the press release attached hereto Exhibit 99.1, announcing its financial results for the quarter ended September 30, 2007.

Item 9.01. Financial Statements and Exhibits.

(c)            Exhibits.

                The following exhibits are furnished with this Form 8-K:

Exhibit     Description

99.1         Press Release dated November 8, 2007.

SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Rockwell Medical Technologies, Inc.
(Registrant)
November 8, 2007
(Date) 		  /s/   THOMAS E. KLEMA
Thomas E. Klema
Vice President & Chief Financial Officer

  Exhibit Index
  99.1 Press release dated November 8, 2007